RAN and ovarian cancer: Ran expression has been verified to be higher in kidney, breast, colon, gastric, pancreatic, lung, and ovarian cancers than in normal groups (Abe et al., 2008; Barrès et al., 2010; Sheng et al., 2018; Lu et al., 2020).